Bogle Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Bogle Investment Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-192,052	Closed	-$2.47M	–	367
2019 Q1	$2.47M	Buy	192,052 +148,052	+336%	+$2.2M	0.19%	134
2018 Q4	$668K	Buy	44,000 +17,376	+65%	+$331K	0.05%	263
2018 Q3	$532K	Sell	26,624 -72,598	-73%	-$1.65M	0.04%	237
2018 Q2	$1.94M	Sell	99,222 -24,565	-20%	-$543K	0.14%	146
2018 Q1	$2.49M	Sell	123,787 -204,668	-62%	-$3.46M	0.19%	137
2017 Q4	$4.35M	Buy	+328,455	New	+$4.95M	0.32%	102
2017 Q1	–	Sell	-344,103	Closed	-$12M	–	413
2016 Q4	$12M	Buy	+344,103	New	+$10.3M	0.83%	38
2014 Q1	–	Sell	-109,205	Closed	-$2.65M	–	419
2013 Q4	$2.65M	Buy	109,205 +36,576	+50%	+$860K	0.22%	142
2013 Q3	$1.56M	Sell	72,629 -83,500	-53%	-$1.97M	0.16%	192
2013 Q2	$3.47M	Buy	+156,129	New	+$3.44M	0.42%	100

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bogle Investment Management's AMAG Position: Q2 2019 in Review

Bogle Investment Management sold out of AMAG Pharmaceuticals (AMAG) in Q2 2019, closing a stake of 192,052 shares — an estimated $2.47M sold.

Bogle Investment Management first reported a position in AMAG in Q2 2013 and held it in 10 quarters. The position peaked at $12M in Q4 2016. 170 funds tracked by Wall St. Rank hold AMAG as of Q2 2019.

Bogle Investment Management reported no remaining AMAG Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Bogle Investment Management sold 192,052 AMAG Pharmaceuticals shares in Q2 2019, an estimated $2.47M.
Bogle Investment Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 10 quarters.
Bogle Investment Management's AMAG Pharmaceuticals position peaked at $12M in Q4 2016.
170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2019.

Based on Bogle Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.